2seventy bio Inc (TSVT)
4.76
-0.17
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Shareholders Equity (Quarterly): 255.30M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 255.30M |
| September 30, 2023 | 306.42M |
| June 30, 2023 | 367.50M |
| March 31, 2023 | 401.32M |
| December 31, 2022 | 310.47M |
| September 30, 2022 | 323.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 378.98M |
| March 31, 2022 | 447.42M |
| December 31, 2021 | 359.82M |
| September 30, 2021 | -58.41M |
| June 30, 2021 | 48.69M |
| December 31, 2020 | 74.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-58.41M
Minimum
Sep 2021
447.42M
Maximum
Mar 2022
267.94M
Average
316.82M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 16.49B |
| Johnson & Johnson | 70.02B |
| Macrogenics Inc | 152.61M |
| Akebia Therapeutics Inc | -30.58M |
| Tango Therapeutics Inc | 253.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 565.43M |
| Total Liabilities (Quarterly) | 310.13M |
| Current Ratio | 3.977 |